Want to see HK:6622 full AI Analyst Report?
Zhaoke Ophthalmology Ltd. (6622) Ratios
Zhaoke Ophthalmology Ltd. Ratios
HK:6622's free cash flow for Q2 2026 was $-76.82M. For the 2026 fiscal year, HK:6622's free cash flow was decreased by $-3.31M and operating cash flow was $-73.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.18 | 5.16 | 5.33 | 10.14 | 24.82 |
| Quick Ratio | 4.14 | 5.11 | 5.32 | 10.14 | 24.82 |
| Cash Ratio | 3.95 | 3.58 | 4.34 | 8.82 | 23.91 |
| Solvency Ratio | -0.42 | -0.59 | -0.90 | -1.71 | -19.22 |
| Operating Cash Flow Ratio | -0.79 | -0.81 | -0.96 | -1.70 | -2.75 |
| Short-Term Operating Cash Flow Coverage | -0.96 | -1.19 | -1.57 | -3.50 | -23.83 |
| Net Current Asset Value | $ 1.01B | $ 1.27B | $ 1.42B | $ 1.75B | $ 2.10B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.11 | 0.10 | 0.05 | 0.01 |
| Debt-to-Equity Ratio | 0.19 | 0.13 | 0.12 | 0.06 | 0.01 |
| Debt-to-Capital Ratio | 0.16 | 0.11 | 0.10 | 0.05 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.18 | 1.18 | 1.09 | 1.04 |
| Debt Service Coverage Ratio | -0.77 | -1.13 | -1.53 | -3.97 | -31.21 |
| Interest Coverage Ratio | -30.11 | -23.99 | -47.54 | -128.64 | -186.93 |
| Debt to Market Cap | 0.19 | 0.35 | 0.11 | 0.07 | 0.01 |
| Interest Debt Per Share | 0.55 | 0.45 | 0.45 | 0.25 | 0.09 |
| Net Debt to EBITDA | 4.69 | 3.51 | 3.73 | 4.12 | 5.54 |
| Profitability Margins | |||||
| Gross Profit Margin | -104.56% | 74.72% | 75.98% | 0.00% | 0.00% |
| EBIT Margin | -855.36% | -410.98% | -2008.36% | 0.00% | 0.00% |
| EBITDA Margin | -687.37% | -362.40% | -1748.60% | 0.00% | 0.00% |
| Operating Profit Margin | -855.36% | -328.88% | -2008.36% | 0.00% | 0.00% |
| Pretax Profit Margin | -653.60% | -342.58% | -2050.60% | 0.00% | 0.00% |
| Net Profit Margin | -653.60% | -342.58% | -2053.54% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -653.60% | -342.58% | -2053.54% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.14% | 100.00% | 100.21% |
| EBT Per EBIT | 76.41% | 104.17% | 102.10% | 100.78% | 584.57% |
| Return on Assets (ROA) | -10.51% | -10.59% | -15.91% | -15.85% | -81.91% |
| Return on Equity (ROE) | -12.91% | -12.50% | -18.80% | -17.34% | -85.52% |
| Return on Capital Employed (ROCE) | -16.57% | -11.81% | -18.07% | -17.01% | -14.48% |
| Return on Invested Capital (ROIC) | -14.09% | -10.59% | -16.37% | -16.30% | -14.39% |
| Return on Tangible Assets | -13.11% | -12.98% | -18.99% | -18.22% | -87.36% |
| Earnings Yield | -14.00% | -38.58% | -19.78% | -28.17% | -111.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.50 | 4.52 | 5.05 | 0.00 | 0.00 |
| Payables Turnover | 199.02 | 14.99 | 3.86 | 0.00 | 0.00 |
| Inventory Turnover | 4.35 | 1.18 | 0.73 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.20 | 0.36 | 0.08 | 0.00 | 0.00 |
| Asset Turnover | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.03 | 0.05 | 0.01 | 0.00 | 0.00 |
| Cash Conversion Cycle | 808.56 | 366.80 | 475.48 | 0.00 | 0.00 |
| Days of Sales Outstanding | 726.55 | 80.84 | 72.22 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 83.85 | 310.31 | 497.77 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1.83 | 24.34 | 94.51 | 0.00 | 0.00 |
| Operating Cycle | 810.40 | 391.15 | 569.99 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.48 | -0.46 | -0.60 | -0.61 | -0.59 |
| Free Cash Flow Per Share | -0.48 | -0.55 | -0.77 | -1.05 | -0.82 |
| Dividend Paid and CapEx Coverage Ratio | -53.73 | -5.76 | -3.40 | -1.39 | -2.59 |
| Capital Expenditure Coverage Ratio | -53.73 | -5.76 | -3.40 | -1.39 | -2.59 |
| Operating Cash Flow Coverage Ratio | -0.89 | -1.06 | -1.36 | -2.51 | -6.62 |
| Operating Cash Flow to Sales Ratio | -8.35 | -3.66 | -17.26 | 0.00 | 0.00 |
| Free Cash Flow Yield | -18.23% | -48.38% | -21.52% | -39.40% | -17.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.19 | -2.59 | -5.06 | -3.55 | -0.90 |
| Price-to-Sales (P/S) Ratio | 46.69 | 8.88 | 103.83 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.92 | 0.32 | 0.95 | 0.62 | 0.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.49 | -2.07 | -4.65 | -2.54 | -5.64 |
| Price-to-Operating Cash Flow Ratio | -5.59 | -2.43 | -6.01 | -4.37 | -7.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.51 | 0.07 | 0.95 | 0.04 | -0.00 |
| Enterprise Value Multiple | -2.10 | 1.06 | -2.21 | 0.36 | 0.47 |
| Enterprise Value | 450.31M | -266.90M | 723.15M | -138.63M | -177.08M |
| EV to EBITDA | -2.10 | 1.06 | -2.21 | 0.36 | 0.47 |
| EV to Sales | 14.46 | -3.85 | 38.57 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.70 | 0.90 | -1.73 | 0.24 | 0.52 |
| EV to Operating Cash Flow | -1.73 | 1.05 | -2.23 | 0.42 | 0.72 |
| Tangible Book Value Per Share | 2.18 | 2.72 | 3.04 | 3.71 | 5.66 |
| Shareholders’ Equity Per Share | 2.88 | 3.48 | 3.77 | 4.33 | 6.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | -0.01 | -0.00 |
| Revenue Per Share | 0.06 | 0.13 | 0.03 | 0.00 | 0.00 |
| Net Income Per Share | -0.37 | -0.43 | -0.71 | -0.75 | -5.18 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.76 | 0.83 | 1.02 | 0.99 | 5.34 |
| Research & Development to Revenue | 4.25 | 2.94 | 17.76 | 0.00 | 0.00 |
| SG&A to Revenue | 1.18 | 1.94 | 1.23 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.20 | 0.12 | 1.17 | 0.00 | 0.00 |
| Income Quality | 1.25 | 1.07 | 0.84 | 0.81 | 0.12 |
Currency in CNY
